Columbia Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,960
| Closed | -$245K | – | 170 |
|
2022
Q3 | $245K | Hold |
2,960
| – | – | 0.06% | 148 |
|
2022
Q2 | $281K | Buy |
+2,960
| New | +$281K | 0.07% | 144 |
|
2021
Q4 | $383K | Hold |
2,960
| – | – | 0.08% | 145 |
|
2021
Q3 | $335K | Hold |
2,960
| – | – | 0.07% | 150 |
|
2021
Q2 | $307K | Sell |
2,960
-60
| -2% | -$6.22K | 0.07% | 150 |
|
2021
Q1 | $253K | Buy |
3,020
+350
| +13% | +$29.3K | 0.05% | 162 |
|
2020
Q4 | $244K | Hold |
2,670
| – | – | 0.05% | 161 |
|
2020
Q3 | $213K | Sell |
2,670
-225
| -8% | -$17.9K | 0.05% | 156 |
|
2020
Q2 | $200K | Sell |
2,895
-1,845
| -39% | -$127K | 0.05% | 146 |
|
2020
Q1 | $298K | Sell |
4,740
-2,865
| -38% | -$180K | 0.07% | 122 |
|
2019
Q4 | $5.91K | Buy |
7,605
+105
| +1% | +$82 | 0.14% | 111 |
|
2019
Q3 | $550K | Sell |
7,500
-1,215
| -14% | -$89.1K | 0.14% | 111 |
|
2019
Q2 | $537K | Buy |
+8,715
| New | +$537K | 0.14% | 110 |
|